MDT

88.44

-0.16%↓

VEEV

284.2

+0.67%↑

A

121.49

+1.08%↑

WBA

11.47

-0.09%↓

HQY

101.96

+0.85%↑

MDT

88.44

-0.16%↓

VEEV

284.2

+0.67%↑

A

121.49

+1.08%↑

WBA

11.47

-0.09%↓

HQY

101.96

+0.85%↑

MDT

88.44

-0.16%↓

VEEV

284.2

+0.67%↑

A

121.49

+1.08%↑

WBA

11.47

-0.09%↓

HQY

101.96

+0.85%↑

MDT

88.44

-0.16%↓

VEEV

284.2

+0.67%↑

A

121.49

+1.08%↑

WBA

11.47

-0.09%↓

HQY

101.96

+0.85%↑

MDT

88.44

-0.16%↓

VEEV

284.2

+0.67%↑

A

121.49

+1.08%↑

WBA

11.47

-0.09%↓

HQY

101.96

+0.85%↑

Search

Geron Corp

Closed

SectorHealthcare

1.42 -1.39

Overview

Share price change

24h

Current

Min

1.38

Max

1.42

Key metrics

By Trading Economics

Income

5.5M

-20M

Sales

-7.9M

40M

Profit margin

-50.085

Employees

229

EBITDA

-375K

-17M

Recommendations

By TipRanks

Recommendations

Buy

12 Months Forecast

+192.86% upside

Dividends

By Dow Jones

Next Earnings

7 Aug 2025

Market Stats

By TradingEconomics

Market Cap

-789M

898M

Previous open

2.81

Previous close

1.42

News Sentiment

By Acuity

46%

54%

149 / 375 Healthcare

Geron Corp Chart

Past performance is not a reliable indicator of future results.

Related News

3 Jul 2025, 23:45 UTC

Acquisitions, Mergers, Takeovers

Orix Corp. USA to Buy Majority Stake in Hilco Global >8591.TO

3 Jul 2025, 23:42 UTC

Market Talk

Gold Edges Higher Amid U.S. Fiscal-Deficit Concerns -- Market Talk

3 Jul 2025, 23:41 UTC

Market Talk

Nikkei May Rise After Solid U.S. Jobs Data -- Market Talk

3 Jul 2025, 23:41 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

3 Jul 2025, 23:15 UTC

Market Talk
Acquisitions, Mergers, Takeovers

Beach Energy Could Smooth Path to Santos Takeover Approval -- Market Talk

3 Jul 2025, 22:59 UTC

Market Talk

Uranium Market About to Enter Lull -- Market Talk

3 Jul 2025, 22:58 UTC

Market Talk

Value Emerging in Diversified Miners Despite Headwinds -- Market Talk

3 Jul 2025, 22:47 UTC

Market Talk

Australian Household Spending Numbers Key Ahead of RBA Meeting -- Market Talk

3 Jul 2025, 22:21 UTC

Earnings

This Summer's Big TV Hit Brings Back Soap Opera Memories -- Barrons.com

3 Jul 2025, 20:50 UTC

Market Talk

Financial Services Roundup: Market Talk

3 Jul 2025, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

3 Jul 2025, 20:50 UTC

Market Talk

Health Care Roundup: Market Talk

3 Jul 2025, 20:41 UTC

Market Talk

KKR Seen As Benefiting From Stabilizing Markets -- Market Talk

3 Jul 2025, 20:41 UTC

Market Talk

Global Equities Roundup: Market Talk

3 Jul 2025, 19:28 UTC

Market Talk

Oil Gives Back Some Gains With OPEC+ in View -- Market Talk

3 Jul 2025, 19:03 UTC

Market Talk

U.S. Natural Gas Retreats Ahead of Long Weekend -- Market Talk

3 Jul 2025, 18:34 UTC

Market Talk

Gold Has Winning Week, But Down Day -- Market Talk

3 Jul 2025, 18:18 UTC

Market Talk

Anticipation for Trump Address Gives Grain Traders Optimism -- Market Talk

3 Jul 2025, 18:06 UTC

Market Talk

Global Equities Roundup: Market Talk

3 Jul 2025, 18:06 UTC

Market Talk

Brazilian Stocks, Bonds Expected to Benefit From Benign Macro Trends -- Market Talk

3 Jul 2025, 17:27 UTC

Market Talk

U.S. Oil Rig Count Continues to Slide -- Market Talk

3 Jul 2025, 16:55 UTC

Earnings

Travel Stocks Could Offer Investors a Glorious -2-

3 Jul 2025, 16:55 UTC

Earnings

Travel Stocks Could Offer Investors a Glorious Trip, This Analyst Says -- Barrons.com

3 Jul 2025, 16:20 UTC

Market Talk

Correction to Health Care Roundup: Market Talk

3 Jul 2025, 16:15 UTC

Market Talk

Oil Futures Lose Ground in Choppy Pre-Holiday Trade -- Market Talk

3 Jul 2025, 16:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

3 Jul 2025, 16:05 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

3 Jul 2025, 16:05 UTC

Market Talk

Gold Futures Fall Following Jobs Report -- Market Talk

3 Jul 2025, 15:47 UTC

Earnings

Honeywell Stock Is on a Roll. It Looks Ready to Break Out. -- Barrons.com

3 Jul 2025, 15:36 UTC

Earnings
Acquisitions, Mergers, Takeovers

Why It's Time to Buy This Rocks and Cement Spinoff Stock You've Probably Never Heard Of -- Barrons.com

Peer Comparison

Price change

Geron Corp Forecast

Price Target

By TipRanks

192.86% upside

12 Months Forecast

Average 4.1 USD  192.86%

High 6 USD

Low 1.5 USD

Based on 7 Wall Street analysts offering 12 month price targets forGeron Corp - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

7 ratings

5

Buy

2

Hold

0

Sell

Sentiment

By Acuity

149 / 375 Healthcare

News Sentiment

Bullish Evidence

Volatility

Below average

News Volume (RCV)

Below average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Geron Corp

Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in myeloid hematologic malignancies for the treatment of low or intermediate-1 risk myelodysplastic syndromes and intermediate-2 or high-risk myelofibrosis. The company was incorporated in 1990 and is headquartered in Foster City, California.